Shareholders and lending institutions
Shareholders:
Local and international institutional and private investors, as well as fund managers and analysts from the broader investment community.
Lending institutions:
South African financial institutions which provide funding and trade finance facilities to the group.
Key engagement issues in 2024
Addressing engagement needs, expectations and concerns
Clicks: Concerns related to the ability to expand the pharmacy network due to the suspension of new retail pharmacy licence applications imposed by the Department of Health (DoH) until Clicks complied with the Constitutional Court judgment on the ownership of the manufacturing pharmacy licence of Unicorn Pharmaceuticals (Unicorn).
Agreement was reached with the DoH that the group would divest its total shareholding in Unicorn to comply with the court ruling. The sale of Unicorn was completed effective 1 August 2024, enabling Clicks to resume its application process for retail pharmacy licences with the DoH. Clicks opened net nine pharmacies over the past year.
Clicks: Impact of the aggressive three-year store expansion strategy announced by the group’s major competitor.
Clicks is committed to expanding its store footprint to at least 1 200, targeting to open 40 to 50 stores and 40 to 50 pharmacies annually. In the past year Clicks opened net 51 stores, bringing the total opened over the past three years to 154. The expansion plan continues to focus on opening convenience format stores, accelerating Clicks’ presence in lower-income areas, targeting upper-income areas in Gauteng where Clicks is under-represented and opening approximately 10 larger format specialist pharmacies following the acquisition of M-Kem.
Clicks: Impact of the weak consumer environment on trading in Clicks due to the pressure on consumer spending from rising food, energy and fuel costs and high interest rates.
While the group is not immune to the downturn in the economic environment, the business model is resilient and the core healthcare markets in which the group trades are highly defensive and non-cyclical, with over 80% of group turnover in defensive categories. Clicks has continued to report volume growth in the past year despite these pressures on consumer spending.
UPD: Impact of the post systems implementation and non-renewal of bulk distribution contracts and plans for the wholesaler to recover market share.
Following the completion of the large-scale systems implementation early in the financial year, performance continued to improve during the year. Operational metrics moved back in line with targets post the implementation at the Lea Glen distribution centre. The rationalisation of the bulk distribution portfolio is aimed at focusing on profitable clients, which has created the capacity for growth of existing profitable clients and to acquire profitable new clients. UPD is expected to recover market share as benefits are realised post the systems implementation and the Clicks Pharmacy purchasing compliance from UPD recovers to the targeted 98%.